Larry Solow: Okay. Okay, I got you. Okay. That’s fair. Understood. Okay. And then just a question for Sunny, just switching gears. Everything sounds pretty good. Obviously, you have some supply chain, more macro issues, and some higher semi-cap semiconductor costs and stuff. But just in general, it sounds like things are pretty good. I realize that, the macro headwinds in general, the economy is not great, but just trying to see specifically for you what else kind of concerns you? Is it just macro €“ these macro supply issues that are maybe not impacting you, but your customers and how hospital budget spending look, I know, I think there was some concern a few weeks ago, I think somebody Omnicell maybe reported and they talked about a capital €“ hospital budgets are not looking as good as maybe some people thought.
So, can you just give us sort of a broad brush on €“ you mentioned just some €“ a tough environment and I get the macro is tough. But trying to figure out barrack specifically what kind of concerns you? Thanks.
Sunny Sanyal: Yeah. So, Larry our customers had very strong bookings in both our fiscal 2021 and fiscal 2022. So, they all had a very strong year and they’re sitting on quite a bit of orders that they’ve taken that are in their backlog. So as you know for us, then that represents the call-offs that we would get to the extent that they have deliveries in this year. So as I look forward and just looking at where we are from a supply chain perspective, I feel good about that. We’ve made quite a bit of progress with our supply chain initiatives. You might recall, we jumped on them early. We got going really fast. We qualified a lot of suppliers. So I feel good about our ability and to progressively have a good year going forward.
I think the risk for me is sitting here not quite fully understanding the situation that our customers might be in with their supply chains and whether they’d be able to get the products out as we would want them to. So that’s the risk that we’re looking at and that’s the unknown here to be fair.
Larry Solow: Okay. So your concerns on the revenue side, whether it be the Medical side or even maybe Industrial from customers, it sounds like Industrial up until now is doing great for you guys or a lot better than sequentially over the last few quarters. Does a slow economy necessarily you would think that would curb spending a little bit? Does that concern you?
Sunny Sanyal: Yeah, it does. But you used the example of Omnicell. I believe Omnicell makes pharmacy cabinets and products like that. They’re signed directly to end users and then their situation is different from ours in the sense that our customers have longer shipment cycles. And so given the volume of business that’s already in their backlog, I feel like we’re in a different place. Our uncertainty is if the economy starts to slow down and orders intake by our customers softens, then that impact is likely to be at the tail end of the year or next year. And so we don’t quite know how to model that in this year. This year we’re — we feel good about at least the current position. Q1 as Sam mentioned is — Q1 tends to be historically a soft quarter for us because of the fiscal year-end of our customers, they’ve already bought a lot of the things that they need for this quarter.
